These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24609521)
1. Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis. Chen D; Shen C; Du H; Zhou Y; Che G Fam Cancer; 2014 Sep; 13(3):449-57. PubMed ID: 24609521 [TBL] [Abstract][Full Text] [Related]
2. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review. Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer]. Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of caveolin in breast cancer: a meta-analysis. Ma X; Liu L; Nie W; Li Y; Zhang B; Zhang J; Zhou R Breast; 2013 Aug; 22(4):462-9. PubMed ID: 23639584 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis. Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis. Zhao S; Qiu Z; He J; Li L; Li W Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749 [TBL] [Abstract][Full Text] [Related]
8. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma. Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568 [TBL] [Abstract][Full Text] [Related]
9. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
10. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis. Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis. Liu X; Huang G; Zhang J; Zhang L; Liang Z PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949 [TBL] [Abstract][Full Text] [Related]
12. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients. Bertino EM; Williams TM; Nana-Sinkam SP; Shilo K; Chatterjee M; Mo X; Rahmani M; Phillips GS; Villalona-Calero MA; Otterson GA Clin Lung Cancer; 2015 Nov; 16(6):466-74. PubMed ID: 26123189 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer. Zhang C; Li J; Han Y; Jiang J Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700 [TBL] [Abstract][Full Text] [Related]
14. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877 [TBL] [Abstract][Full Text] [Related]
15. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer. Xu XY; Lin N; Li YM; Zhi C; Shen H Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236 [TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer. Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis. Tan Z; Shen W Oncotarget; 2017 Apr; 8(16):27137-27144. PubMed ID: 28404927 [TBL] [Abstract][Full Text] [Related]
18. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry. Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531 [TBL] [Abstract][Full Text] [Related]
19. [Study on expression and methylation of caveolin 1 gene in non-small cell lung cancers]. Zhang YX; Chen HL; Ye B; Yang F; Yu LY Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):300-4. PubMed ID: 18956646 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis. Selvaraj G; Kaliamurthi S; Lin S; Gu K; Wei DQ Curr Med Chem; 2019; 26(42):7694-7713. PubMed ID: 30182835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]